Silvia Marchetti

765 total citations
25 papers, 402 citations indexed

About

Silvia Marchetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Silvia Marchetti has authored 25 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Silvia Marchetti's work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and HER2/EGFR in Cancer Research (3 papers). Silvia Marchetti is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and HER2/EGFR in Cancer Research (3 papers). Silvia Marchetti collaborates with scholars based in Italy, Netherlands and United Kingdom. Silvia Marchetti's co-authors include Jan H.M. Schellens, Armando Santoro, Luca Toschi, G. Edwards, J. Wanders, Larisa Reyderman, Marco Alloisio, Marja Mergui‐Roelvink, Daoud Rahal and Fabio Grizzi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Silvia Marchetti

25 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Marchetti Italy 8 242 126 88 52 35 25 402
Whitney P. Kirschbrown United States 10 214 0.9× 107 0.8× 104 1.2× 111 2.1× 53 1.5× 16 416
Danae Hamouda United States 11 230 1.0× 67 0.5× 37 0.4× 156 3.0× 81 2.3× 33 460
Xiaojia Wang China 13 339 1.4× 163 1.3× 68 0.8× 216 4.2× 28 0.8× 46 620
Baha Zengel Türkiye 9 180 0.7× 73 0.6× 38 0.4× 111 2.1× 20 0.6× 44 426
Nicola Cresti United Kingdom 13 331 1.4× 80 0.6× 54 0.6× 216 4.2× 51 1.5× 34 639
Christina Guo United Kingdom 8 129 0.5× 167 1.3× 61 0.7× 111 2.1× 46 1.3× 26 350
Xiaoyuan Li China 13 117 0.5× 93 0.7× 28 0.3× 172 3.3× 63 1.8× 39 523
Konstantinos Koutsoukos Greece 13 251 1.0× 100 0.8× 42 0.5× 181 3.5× 52 1.5× 55 499
John L. Zapas United States 10 221 0.9× 53 0.4× 15 0.2× 69 1.3× 70 2.0× 23 381
Silverio Tomao Italy 13 253 1.0× 60 0.5× 35 0.4× 177 3.4× 84 2.4× 23 506

Countries citing papers authored by Silvia Marchetti

Since Specialization
Citations

This map shows the geographic impact of Silvia Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Marchetti more than expected).

Fields of papers citing papers by Silvia Marchetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Marchetti. The network helps show where Silvia Marchetti may publish in the future.

Co-authorship network of co-authors of Silvia Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Marchetti. A scholar is included among the top collaborators of Silvia Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Marchetti. Silvia Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bardellini, Elena, et al.. (2025). Effectiveness of Activated Charcoal Toothpaste vs. 6% Hydrogen Peroxide Whitening Pen—An In Vitro Study. Dentistry Journal. 13(5). 216–216. 1 indexed citations
2.
Tosi, Federica, Lisa Salvatore, Sara Lonardi, et al.. (2024). Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study. ESMO Open. 9(10). 103929–103929. 2 indexed citations
3.
Hedayat, Somaieh, Andrea Lampis, Georgios Vlachogiannis, et al.. (2019). Circulating miR-652-3p as a biomarker of drug resistance in metastatic colorectal cancer patients. Annals of Oncology. 30. vii4–vii4. 1 indexed citations
4.
Huijberts, Sanne C.F.A., Emilie M.J. van Brummelen, Robin M.J.M. van Geel, et al.. (2019). Phase I study of lapatinib and trametinib in patients with KRAS mutant colorectal, non-small cell lung and pancreatic cancer. Annals of Oncology. 30. v178–v179. 2 indexed citations
5.
Jacobs, Bart, Dick Pluim, Hilde Rosing, et al.. (2018). Phase I pharmacological study of continuous chronomodulated capecitabine treatment. Annals of Oncology. 29. viii662–viii663. 1 indexed citations
6.
Marchetti, Silvia, et al.. (2018). Utilizzo degli antibiotici: risultati di un sondaggio condotto su un campione di dentisti italiani. Dental Cadmos. 86(3). 204–204. 2 indexed citations
7.
Marchetti, Silvia, et al.. (2018). Toda educación es sexual. 1 indexed citations
8.
Puviani, Mario, Silvia Marchetti, Paolo Pavone, et al.. (2017). Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial. Current Medical Research and Opinion. 33(7). 1255–1259. 19 indexed citations
9.
Toschi, Luca, Egesta Lopci, Federico Marchesi, et al.. (2016). Correlation of metabolic information on 18F-FDG PET with the tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) candidate to upfront surgery. Annals of Oncology. 27. iv8–iv8. 1 indexed citations
10.
Weger, Vincent A. de, Frederik E. Stuurman, Marja Mergui‐Roelvink, et al.. (2016). A phase I dose-escalation trial of bi-daily (BID) weekly oral docetaxel as ModraDoc006 in combination with ritonavir. Annals of Oncology. 27. vi127–vi127. 2 indexed citations
11.
Lopci, Egesta, Luca Toschi, Fabio Grizzi, et al.. (2016). Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery. European Journal of Nuclear Medicine and Molecular Imaging. 43(11). 1954–1961. 116 indexed citations
12.
Sanctis, Rita De, Andrea Marrari, Silvia Marchetti, et al.. (2015). Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma. Drug Design Development and Therapy. 9. 5785–5785. 30 indexed citations
13.
Devriese, Lot A., Petronella O. Witteveen, Silvia Marchetti, et al.. (2012). Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment. Cancer Chemotherapy and Pharmacology. 70(6). 823–832. 37 indexed citations
14.
Devriese, Lot A., Marja Mergui‐Roelvink, J. Wanders, et al.. (2012). Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole. Investigational New Drugs. 31(2). 381–389. 21 indexed citations
15.
Wanders, J., G. Edwards, Larisa Reyderman, et al.. (2010). 574 Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole (KET). European Journal of Cancer Supplements. 8(7). 181–181. 6 indexed citations
16.
Marchetti, Silvia, Marja Mergui‐Roelvink, Larisa Reyderman, et al.. (2010). Eribulin mesylate pharmacokinetics in patients with hepatic impairment.. Journal of Clinical Oncology. 28(15_suppl). 2582–2582. 17 indexed citations
17.
Marchetti, Silvia & Jan H.M. Schellens. (2007). The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials. British Journal of Cancer. 97(5). 577–581. 104 indexed citations
18.
Marchetti, Silvia, et al.. (2002). Effect of Physical Activity on the Pharmacokinetics of Ceftazidime in Mice. Chemotherapy. 48(4). 161–163. 2 indexed citations
19.
Rainaldi, Giuseppe, et al.. (1998). Absence of mutations in the highest mutability region of the p-53 gene in tumour-derived CHEF18 Chinese hamster cells. Mutagenesis. 13(2). 153–155. 5 indexed citations
20.
Franceschetti, Giovanni, et al.. (1998). [Minimally invasive treatment of female urinary incontinence due to sphincter incompetence].. PubMed. 50(1). 17–24. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Whitney P. Kirschbrown Breakdown of academic impact, for papers by Danae Hamouda Breakdown of academic impact, for papers by Xiaojia Wang Breakdown of academic impact, for papers by Baha Zengel Breakdown of academic impact, for papers by Nicola Cresti Breakdown of academic impact, for papers by Christina Guo Breakdown of academic impact, for papers by Xiaoyuan Li Breakdown of academic impact, for papers by Konstantinos Koutsoukos Breakdown of academic impact, for papers by John L. Zapas Breakdown of academic impact, for papers by Silverio Tomao
Rankless by CCL
2026